Trials / Recruiting
RecruitingNCT07223580
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
Evaluating The Role Of Corticosteroids In Post-Ureteroscopy Recovery For Urinary Calculi
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to evaluate if corticosteroid (prednisone) after ureteroscopy and placement of the stent will help alleviate postoperative pain control in addition to other normal postoperative pain medications
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Corticosteroid | In addition to the standard of care postoperative ureteroscopy medication, participants will be given prednisone 25 mg orally, once a day for 5 days post-surgery. |
| OTHER | Placebo | In addition to the standard of care postoperative ureteroscopy medication, participants will be given a placebo pill orally, once a day for 5 days post-surgery. |
Timeline
- Start date
- 2026-01-23
- Primary completion
- 2027-01-01
- Completion
- 2027-12-01
- First posted
- 2025-11-03
- Last updated
- 2026-02-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07223580. Inclusion in this directory is not an endorsement.